For Some African-Americans, Genetic Testing Reopens Past Wounds
By Amy Dockser Marcus,
The Wall Street Journal
| 07. 14. 2018
Late last year, Justina Crawford decided to swab the inside of her mouth for a saliva sample to do a DNA test.
Ms. Crawford, a 30-year-old working in Boston who is African-American, had never done a DNA test before because she worried about who would have access to her genetic information. But her growing curiosity about her family history led her to set her reservations aside. “I want to know my roots,” she said, and purchased a kit from African Ancestry Inc., a DNA testing company.
Scientists and private genetic testing companies are making a push to enroll more African-Americans in genetic research and databases. As the popularity and wider availability of genetic testing grows, so have calls from the scientific community about the need for genetic diversity in future research. In the past, genomic research was predominantly skewed to people of European ancestry. As a result, African-Americans—as well as people of different demographic backgrounds—weren’t well represented in some important health research.
But before they sign up, many African-Americans have to overcome concern about potential misuse of DNA results and...
Related Articles
It’s been a busy couple of months in biopolitics, with developments in the US, UK, China, Japan, and implicitly on Mars. Time for a brief roundup.
• • •
Bioethics needs an update
The National Research Act is now 50 years old. It was signed into law on July 12, 1974, as a direct response to publicity about the 1932 “Tuskegee Study of Untreated Syphilis in the Negro Male.” The Hastings Bioethics Forum celebrated its anniversary with an...
By Robert Resta, The DNA Exchange | 07.22.2024
Medical geneticists and genetic counselors have an often complicated and at times tense relationship with people with disabilities, their families, advocates, and scholars. Geneticists are strong advocates and supporters for all of their patients, regardless of their abilities and disabilities...
By Katherine Bourzac, Nature | 07.10.2024
Image courtesy National Human Genome Research Institute
The U.S. Food and Drug Administration (FDA) is supposed to encourage effective medical advances while also ensuring that patients and research subjects are protected. This dual mandate demands tricky judgment calls that are made more difficult by outside pressures of several kinds, political, judicial, and especially commercial. This April story at Bloomberg examines one deeply troubling pattern of regulatory capture:
Americans Are Paying Billions to Take Drugs That Don’t Work
Companies are increasingly...